INBS
Income statement / Annual
Last year (2024), Intelligent Bio Solutions Inc.'s total revenue was $3.11 M,
an increase of 147.58% from the previous year.
In 2024, Intelligent Bio Solutions Inc.'s net income was -$10.16 M.
See Intelligent Bio Solutions Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
| Operating Revenue |
$3.11 M |
$1.26 M |
$0.00 |
$1.98 M |
$188,744.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$1.69 M
|
$930,204.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$1.43 M
|
$326,668.00
|
$0.00
|
$1.98 M
|
$188,744.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0.46
|
0.26
|
0
|
1
|
1
|
0
|
0
|
0
|
| Research and Development Expenses |
$1.67 M
|
$507,424.00
|
$3.85 M
|
$4.27 M
|
$588,206.00
|
$3.18 M
|
$2.53 M
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$4.92 M
|
$3.71 M
|
$2.43 M
|
$3.55 M
|
$2.08 M
|
$139,095.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$33,902.00
|
| Selling, General & Administrative Expenses |
$9.26 M
|
$8.03 M
|
$4.92 M
|
$3.71 M
|
$2.43 M
|
$3.55 M
|
$2.08 M
|
$172,997.00
|
| Other Expenses |
$776,498.00
|
$0.00
|
-$437,146.00
|
-$947,409.00
|
-$188,744.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$11.71 M
|
$8.76 M
|
$8.34 M
|
$7.03 M
|
$2.83 M
|
$6.73 M
|
$4.60 M
|
$172,997.00
|
| Cost And Expenses |
$13.39 M
|
$9.69 M
|
$8.34 M
|
$7.03 M
|
$2.83 M
|
$6.73 M
|
$4.60 M
|
$172,997.00
|
| Interest Income |
$84,822.00
|
$9,676.00
|
$14,426.00
|
$13,806.00
|
$97.00
|
$188.00
|
$564.00
|
$151,282.00
|
| Interest Expense |
$167,140.00
|
$223,534.00
|
$7,539.00
|
$1.09 M
|
$457,745.00
|
$664,840.00
|
$453,872.00
|
$0.00
|
| Depreciation & Amortization |
$1.20 M
|
$966,732.00
|
$8.34 M
|
$5.21 M
|
$2.60 M
|
$5.83 M
|
$4.60 M
|
$188,724.00
|
| EBITDA |
-$8.81 M |
-$9.47 M |
$30,825.00 |
-$1.82 M |
-$561,189.00 |
-$1.50 M |
-$416,916.00 |
-$151,282.00 |
| EBITDA Ratio |
-2.83
|
-5.94
|
0
|
-3.61
|
-14.34
|
0
|
0
|
0
|
| Operating Income Ratio |
-3.3
|
-10.02
|
0
|
-2.81
|
-14.34
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$92,242.00
|
$1.93 M
|
$2,900.00
|
-$1.71 M
|
-$457,745.00
|
-$664,840.00
|
-$453,308.00
|
-$138,672.00
|
| Income Before Tax |
-$10.19 M
|
-$10.66 M
|
-$8.33 M
|
-$8.52 M
|
-$3.16 M
|
-$7.39 M
|
-$5.06 M
|
-$311,672.00
|
| Income Before Tax Ratio |
-3.27
|
-8.48
|
0
|
-4.3
|
-16.76
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$190,699.00
|
-$27,925.00
|
$2.50 M
|
$550,263.00
|
-$57,691.00
|
-$36,392.00
|
-$167,006.00
|
| Net Income |
-$10.16 M
|
-$10.63 M
|
-$8.31 M
|
-$7.04 M
|
-$3.16 M
|
-$7.34 M
|
-$5.02 M
|
-$340,006.00
|
| Net Income Ratio |
-3.26
|
-8.46
|
0
|
-3.55
|
-16.76
|
0
|
0
|
0
|
| EPS |
-6.38 |
-10.58 |
-11.33 |
-16.22 |
-8.92 |
-21.01 |
-14.6 |
-0.99 |
| EPS Diluted |
-6.38 |
-10.58 |
-11.33 |
-16.22 |
-8.92 |
-21.01 |
-14.6 |
-0.99 |
| Weighted Average Shares Out |
$3.19 M
|
$2.01 M
|
$1.47 M
|
$867,900.00
|
$709,200.00
|
$698,560.00
|
$687,500.00
|
$687,500.00
|
| Weighted Average Shares Out Diluted |
$3.19 M
|
$2.01 M
|
$1.47 M
|
$867,900.00
|
$709,200.00
|
$698,560.00
|
$687,500.00
|
$687,500.00
|
| Link |
|
|
|
|
|
|
|
|
